Alzheimer's Invest Information

Stocks
Cassava Sciences: Analysts See 300% UpsideDespite Controversies Oct 30, 2024
Companies
Athira Pharma Announces Key Milestones with Upcoming Presentation of LIFT-AD Clinical Trial Results for Alzheimer's Treatment Aug 2, 2024
Companies
FDA Approves Lilly's Kisunla™ for Early Symptomatic Alzheimer's Jul 3, 2024
Companies
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus Jun 10, 2024
Companies
Athira Pharma Unveils Encouraging Clinical and Preclinical Results for Fosgonimeton at the AD/PD™ 2024 Conference Mar 9, 2024
Companies
Biogen Showcases Fresh Insights on Alzheimer's Disease at AD/PD™ 2024 Conference Mar 5, 2024
Biotechnology
Athira Pharma Showcases Neuroprotective Properties of Fosgonimeton in Alzheimer's Disease Models Nov 16, 2023
Companies
Athira Pharma Demonstrates Promising Neuroprotective Abilities of Fosgonimeton in Alzheimer's Disease Models Nov 15, 2023